Feasibility Study of Radiation Therapy With Wide Detector 4DCT Scanning for Primary or Metastatic Lung Cancer
Conditions: the Diffenence of Different Detector Row 4DCT ，Especially in Artifects，Radiation Dose and Target Volume Interventions: Other: Extra 4DCT scan Sponsors: Tianjin Medical University Cancer Institute and Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Physical Activity Behavioral Change Intervention in Lung Cancer Survivors: Pilot Study
Conditions: Lung Cancer; Sedentary Behavior; Fatigue Interventions: Behavioral: Physical activity in the community; Behavioral: Conventional intervention Sponsors: University Ramon Llull; Institut Catal à d ' Oncologia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer
Conditions: Adult Interventions: Biological: GT201 injection in combination with teraplizumab injection Sponsors: Grit Biotechnology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
PPIO-006 Primary Tumor Resection for IVa NSCLC
Conditions: Non-small-cell Lung Cancer (NSCLC) Interventions: Procedure: Primary tumor resection or not Sponsors: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University; First Affiliated Hospital of Chongqing Medical University; Xinqiao Hospital of Chongqing Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Conditions: Lung Cancer, Nonsmall Cell; Esophageal Carcinoma Interventions: Drug: Camrelizumab; Drug: Thalidomide 50mg; Drug: Thalidomide 100mg; Drug: Thalidomide 200mg; Drug: Chemotherapy Sponsors: Henan Cancer Hospital; First Affiliated Hospital Xi ' an Jiaotong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on LIRAscore
Conditions: Non-small Cell Lung Cancer Sponsors: Nanfang Hospital, Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Effects of Digital Therapeutic in Whole Process Management of Lung Cancer
Conditions: Application of Digital Therapeutic in Lung Cancer Whole Process Management Interventions: Other: UHealth digital therapeutic Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Molecular Diagnosis of Lung Cancer Via Bronchoscopy: The Significance of Bronchial Liquid Biopsy (ctDNA and ctRNA)
Conditions: Non Small Cell Lung Cancer Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
A Phase II Study of MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer
Conditions: Extensive-stage Small-cell Lung Cancer Interventions: Drug: MGC018 Sponsors: Georgetown University; MacroGenics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6
Conditions: Metastatic Nonsmall Cell Lung Cancer Interventions: Drug: [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G. Sponsors: University of California, Davis; United States Department of Defense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
Conditions: Advanced Heart Failure; Advanced Non-colorectal Gastro-intestinal Cancer; Advanced Lung Cancer Interventions: Behavioral: Tier - Palliative Care Sponsors: Icahn School of Medicine at Mount Sinai; National Institute of Nursing Research (NINR) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Conditions: Lung Cancer, Non-small Cell; Lung Cancer Metastatic; Solid Tumor, Adult; Advanced Cancer; Lung Cancer, Small Cell; Metastatic Colorectal Cancer; Metastatic Renal Cell Carcinoma; Metastatic Hepatocellular Carcinoma; Metastatic Sarcoma; Metastatic Osteosarcoma Interventions: Biological: KB707 Sponsors: Krystal Biotech, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
Conditions: RAS Mutation; Ras (Kras or Nras) Gene Mutation; Colorectal Cancer Recurrent; Pancreas Cancer; Lung Cancer; Melanoma; Refractory Cancer Interventions: Drug: Leflunomide; Drug: The combination of MEK inhibitor + hydroxychloroquine( plaquenil) ± bevacizumab Sponsors: N.N. Petrov National Medical Research Center of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Aumolertinib in EGFR-Mutant Resected Stage IB-IIIA NSCLC (AERESA).
Conditions: Lung Cancer Interventions: Drug: Aumolertinib Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
Conditions: Non Small Cell Lung Cancer; Breast Cancer; Colorectal Cancer; Gastric Cancer; Liver Cancer; Advanced Cancer; Immune Checkpoint Inhibitor Sponsors: Gene Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
